In addition, GHR SNP promotes lung cancer progression by impairment of cytokine signaling 2 (SOCS2)‐mediated degradation 7; meanwhile, one review focused on the description of the inhibitors of the GHR/Janus kinase 2/signal transducers and activators of transcription pathway, which also includes SOCS1, SOCS2 and SOCS3 8. The gene discussed is GHR; the disease is lung cancer.